Search
Taltobulin
go.drugbank.com/drugs/DB20832ExperimentalTaltobulin is a small molecule drug. Taltobulin has a monoisotopic molecular weight of 473.33 Da.
Categories: P-glycoprotein substratesTabimorelin
go.drugbank.com/drugs/DB20892ExperimentalTabimorelin is a small molecule drug. The usage of the INN stem '-relin' in the name indicates that Tabimorelin is a pituitary hormone-release stimulating peptide. Tabimorelin has a monoisotopic molecular weight of 528.31 Da.
Categories: Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 CYP3A4 InhibitorsBesigomsin
go.drugbank.com/drugs/DB20894ExperimentalBesigomsin is a small molecule drug. Besigomsin has a monoisotopic molecular weight of 416.18 Da.
Categories: P-glycoprotein inhibitors, Cytochrome P-450 SubstratesDapitant
go.drugbank.com/drugs/DB20991ExperimentalThe usage of the INN stem '-pitant' in the name indicates that Dapitant is a neurokinin NK1 (substance P) receptor antagonist. Dapitant has a monoisotopic molecular weight of 561.29 Da.
Lapisteride
go.drugbank.com/drugs/DB21206ExperimentalLapisteride is a small molecule drug. The usage of the INN stem '-steride' in the name indicates that Lapisteride is a androgen/anabolic steroid. Lapisteride has a monoisotopic molecular weight of 464.3 Da.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 SubstratesMetacetamol
go.drugbank.com/drugs/DB21287ExperimentalMetacetamol is a small molecule drug. Metacetamol has a monoisotopic molecular weight of 151.06 Da.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2E1 InhibitorsImnopitant
go.drugbank.com/drugs/DB21456ExperimentalThe usage of the INN stem '-pitant' in the name indicates that Imnopitant is a neurokinin NK1 (substance P) receptor antagonist. Imnopitant has a monoisotopic molecular weight of 550.22 Da.
Nivasorexant
go.drugbank.com/drugs/DB21506ExperimentalNivasorexant is a small molecule drug. The usage of the INN stem '-orexant' in the name indicates that Nivasorexant is a orexin receptor antagonist. Nivasorexant has a monoisotopic molecular weight of 429.19 Da.
Categories: Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP2C9 InhibitorsZastaprazan
go.drugbank.com/drugs/DB21524InvestigationalZastaprazan is a small molecule drug. The usage of the INN stem '-prazan' in the name indicates that Zastaprazan is a proton pump inhibitor, not dependent on acid activation. Zastaprazan is under investigation in clinical trial NCT058148...
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 SubstratesAlpibectir
go.drugbank.com/drugs/DB21561InvestigationalAlpibectir is a small molecule drug. Alpibectir is under investigation in clinical trial NCT06748937 (A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With Ethionamide). Alpibectir has a monoisoto...
Categories: P-glycoprotein inhibitors, Cytochrome P-450 CYP3A Inhibitors